-
Idaho Press-Tribune - Tue Nov 3, 1:30 am ET
LEWISTON, Idaho (AP) — Harold "Bud" Poxleitner, 67, and Robert Braucher, 40, are cousins who were both paralyzed after separate accidents — Poxleitner in a 1968 logging accident, and Braucher in a 2003 automobile accident. Now the two are preparing to fly to Cologne, Germany, for stem cell treatment that they hope will restore some of their ability to move, feel and otherwise take as many steps ...
-
EurekAlert! - Thu Nov 5, 11:50 am ET
( Lifespan ) Rhode Island Hospital has received an $11 million grant that will fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration in lung and marrow diseases. The 5-year grant, awarded to Peter Quesenberry, MD, director of hematology/oncology at Rhode Island Hospital, also provides funding for the development of a ...
-
PRWeb via Yahoo! News - Tue Nov 3, 2:00 am ET
A bold new approach using adult stem cell therapy has created an international medical first and raised the hope of patients with pulmonary fibrosis, a life threatening disease with as yet no known cure.
-
antiMUSIC - Sat Nov 7, 3:35 am ET
A top story from this week. Today's roundup of quick music news stories
-
ScienceBlogs - Fri Oct 30, 9:47 am ET
Over at the Knight Science Tracker , Charlie Petit has a round-up on news coverage of the California Institute for Regenerative Medicine's first significant research grants for stem cell research. Though much of the focus in California and nationally has obviously been on the promise of embryonic stem cell research, only four of the 14 funded projects involve these type of stem cells. The ...
-
redOrbit - Tue Nov 3, 3:11 pm ET
Stem cells isolated from the brain of adult mice (adult neural stem cells [aNSCs]) have shown very modest therapeutic effects in a mouse model of the chronic inflammatory neurodegenerative disease multiple sclerosis.
-
KTVB Boise - Mon Nov 2, 1:58 pm ET
LEWISTON -- Cottonwood resident Harold "Bud" Poxleitner was paralyzed in 1968 after a logging accident. His cousin, 40-year-old Robert Braucher, was paralyzed in 2003 in a car crash. Now the two are preparing to fly to Cologne, Germany, for stem cell treatment, the Lewiston Tribune reports. Poxleitner, who is paralyzed from the waist down, says he's just hoping to get rid of the pain in his ...
-
The Sacramento Bee - Thu Nov 5, 3:02 am ET
One thing that has always set California apart is our drive to innovate. That spirit is part of our DNA. It's evident all across California in everything from business to the environment to public policy.
-
AP via Yahoo! News - Mon Nov 9, 7:33 pm ET
British scientists begin a new study on Tuesday to consider how human DNA is used in animal experiments and to determine what the boundaries of such controversial science might be.
-
Ventura County Star - Mon Nov 2, 2:03 am ET
Gregory Pence, a medical school and philosophy professor at the University of Alabama at Birmingham who is internationally known for defending cloning and genetically modified food, will speak next week at California Lutheran University in Thousand Oaks. “Genetically modified food and stem cells are topics that affect every American,” said Pence, noting the topics should resonate with ...
-
Investor's Business Daily via Yahoo! Finance - Fri Nov 6, 7:02 pm ET
Skin stem cell spray heals burns
-
New York Times - Mon Nov 9, 11:42 am ET
Salk Institute scientists found that dual-purpose switches controlled many of the genes activated in the regenerating cells of a zebra fish’s tail.
-
DrugDiscoveryOnline - Thu Nov 5, 1:02 am ET
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer technology, announced recently the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months. The Phase I ...
-
Business Wire via Yahoo! Finance - Tue Nov 3, 8:00 am ET
SAN DIEGO----Entest BioMedical Inc. announced today that it has signed a Letter of Intent with Quantum Advisors, a San Diego based biotechnology consulting firm, to assist Entest with the development of its Stem Cell Therapeutic Treatment for Chronic Obstructive Pulmonary Disease .
-
Coeur d'Alene Press - 59 minutes ago
Rami Amaro can tell as soon as she wakes up if it's one of the bad days. Maybe she can't move her right arm, or she can't see out of one eye. The worst days she'll feel the banding -- cruelly nicknamed the "MS hug" -- where the muscles around her rib cage squeeze her like a python.